Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Rising Pharmaceuticals launches Pregabalin Capsules in US market

Posted On: 2019-07-22 11:59:02

Laurus Labs Ltd. (BSE: 540222, NSE: Lauruslabs, ISIN: INE947Q01010), a leading research and development driven pharmaceutical company along with its exclusive distribution partner Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company, announce the launch of the generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, & 300 mg) in US market. Rising recently received the final approval from the U.S. Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA).

Pregabalin Capsules are indicated for management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, for adjunctive therapy for the treatment of partial onset seizures in patients 4 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury. The product should be taken only as prescribed. Pregabalin Capsules and had U.S. sales of approximately $5,497 million for the 12 months ending March 2019, according to IMS Health.

"Laurus Labs is a fully integrated pharmaceutical company, backed by the state of the art manufacturing facilities in Visakhapatnam, Andhra Pradesh. We are happy to develop and manufacture the Pregabalin capsules for our exclusive distribution partner Rising Pharmaceuticals in US. Currently we have 5 billion units per year capacity which can be expanded to 8 million units per year based on the demand. As we move forward in the FDF segment backed by our strong API manufacturing facilities, with strategic partnerships in place, we will strengthen our portfolio for driving long-term, sustainable growth by leveraging our partnerships and global presence," said Dr. Satyanarayana Chava, Founder & CEO, Laurus Labs.

"The commercialization of Pregabalin Capsules is one of the largest volume launches for the company this year and will provide a cost effective treatment option for people living with debilitating neuropathic pain conditions," said Vimal Kavuru, Chief Executive Officer for Rising Pharmaceuticals.

Rising Pharmaceuticals sells generic prescription products and over-the-counter pharmaceutical products under the Rising label to leading wholesalers, chain drug stores, distributors and mass merchandisers.

Shares of Laurus Labs Ltd was last trading in BSE at Rs.350.4 as compared to the previous close of Rs. 350.05. The total number of shares traded during the day was 359 in over 25 trades.

The stock hit an intraday high of Rs. 351.05 and intraday low of 350. The net turnover during the day was Rs. 125705.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Ajmera Realty and Infra India Ltd awarded Developer of the Year - Residential category award

CARE reaffirms ratings of Chaman Lal Setia Exports Ltd

Hon'ble NCLAT upholds the Resolution Plan of MBL Infra

Avana's Water Conservation Solution Becomes Best CSR Idea Of The Year

Coffee Day Enterprises Ltd update On Debt Position

Mahindra inaugurates its 1st automotive assembly plant in Sri Lanka, expands global footprint

TVS Motor Singapore invests US$ 3.2 Million in Predictronics Corporation

NACL Industries Ltd reports financial results for Q1 FY20

Precision Camshafts Limited - Q1 FY2020 results

SREI Equipment Finance Ltd's NCD issue opens on Aug 16, 2019

Transform Banking with Newgen at FIBAC 2019

Hero MotoCorp surpasses milestone of 1000 women employees

Sun Pharma and China Medical System Holdings Enter into Licensing Agreement for Generic Products in Mainland China

IFIN & RCFL initiate proceedings against SKIL Infrastructure Ltd

Kridhan Infra Limited - VNC wins new orders worth INR 145 Crores

Ram Ratna Wires Ltd fixes Aug 30, 2019 as record date for dividend

Himatsingka Seide Ltd clarifies on certain media reports

Master Trust Ltd fixes Aug 27, 2019 as record date for sub-division of equity shares

Advik Laboratories Ltd Board to consider sale of manufacturing unit

CARE downgrades ratings of Walchandnagar Industries Ltd

Super Crop Safe Limited announces Financial Results for Q1FY20

Info Edge India Ltd to invest in Shopkirana

Hinduja Ventures Ltd board to consider reorganizaiton of businesses on Aug 23, 2019

Voltas launches new Brand Shop at Gajuwaka, Visakhapatnam

CRISIL downgrades ratings of DCM Ltd

Lupin receives U.S. FDA approval for Hydrocortisone Valerate Cream

Birlasoft Wins Two Oracle Excellence Awards for 2019

TCS Interactive Wins 2019 Red Dot: Best of the Best Award in Brands and Communication Design

Blue Star Ltd - Financial Highlights for Q1 FYF20

Hindustan Foods Ltd - Q1-FY20 Performance Highlights

Omaxe Ltd Consolidated PAT for Q1 FY19-20 at Rs 14.91 cr

QGO Finance Ltd board to consider NCD issue on Aug 21, 2019

Mindteck reports financial results for Q1 2019-20

Ramkrishna Forgings Ltd's resolution plan for ACIL Ltd accepted

KNR Constructions Ltd to sell stake in SPV for Rs. 95.79 crores

Panacea Biotec announces Q1 FY20 results

IOB offers Retail Loans through the online portal PSB Loans in 59 minutes.com

Travel Money with YES BANK to launch Forex Card on Visa network

Mishtann Foods reports 22.1% increase in Q1FY2020 PAT at INR 3.14 crore

India Ratings assigns 'Ind AA- / Negative' For Indian Overseas Bank Bonds

YES BANK raises Rs. 1,930 crores through Qualified Institutions Placement route

Hero MotoCorp Ltd updates on closure of production facilities

Voltas Beko launches India's first 5 Star rated Washing Machines

Titagarh Wagons Ltd consortium bags order for Pune Metro Rail project

PVR launches sub-brand PVR UTSAV in Satna

Brigade Enterprises Ltd fixes Aug 29, 2019 as record date for bonus issue

India Infoline Finance announces consolidated PAT of Rs. 181 crore

West Coast Paper Mills Limited : Q1FY20 Results

Dynacons Systems & Solutions Ltd Board approves interim dividend of Rs. 0.50

Man Industries India Limited reports Q1FY20 Financial Results







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019